Eli Lilly (LLY) Stock Buyback History
TTM buyback yield 0.43% · Shareholder yield (TTM) 0.43%.
Eli Lilly
LLY
TTM buyback yield
0.43%
Shareholder yield (TTM)
0.43%
5Y share count change
-6.1%
TTM buyback spend
$4.11B
SBC coverage (TTM)
6.56x
Diluted vs basic shares (annual)
Weighted average shares from the income statement: diluted (EPS denominator and typical buyback-yield basis) compared with basic.
Shares outstanding (annual)
Year-over-year change in diluted weighted average shares (industry-standard for EPS and per-share capital return). Green is fewer shares vs the prior fiscal year; red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield
Buybacks vs stock-based compensation
TTM coverage: 6.56x (buybacks ÷ SBC). Bars are fiscal-year totals.
Buyback spending history
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $4.11B | $626.00M | $3.48B | 0.90B | -0.7% | 0.43% |
| 2024 | $2.50B | $645.60M | $1.85B | 0.90B | 0.1% | 0.36% |
| 2023 | $750.00M | $628.50M | $121.50M | 0.90B | -4.9% | 0.14% |
| 2022 | $1.50B | $371.10M | $1.13B | 0.95B | -0.4% | 0.43% |
| 2021 | $1.25B | $342.80M | $907.20M | 0.95B | -0.3% | 0.47% |
| 2020 | $500.00M | $308.10M | $191.90M | 0.96B | -0.1% | 0.31% |
| 2019 | $4.40B | $312.40M | $4.09B | 0.96B | -7.4% | 3.50% |
| 2018 | $4.15B | $279.50M | $3.87B | 1.03B | -1.7% | 3.49% |
| 2017 | $299.80M | $281.30M | $18.50M | 1.05B | -4.4% | 0.34% |
| 2016 | $600.10M | $255.30M | $344.80M | 1.10B | -0.4% | 0.74% |
| 2015 | $749.50M | $217.80M | $531.70M | 1.11B | -0.5% | 0.80% |
| 2014 | $800.00M | $156.00M | $644.00M | 1.11B | -0.6% | 1.04% |
| 2013 | $1.70B | $144.90M | $1.55B | 1.12B | -2.6% | 2.98% |
| 2012 | $721.10M | $141.50M | $579.60M | 1.15B | 2.9% | 1.28% |
| 2011 | $0.00 | $147.40M | −$147.40M | 1.11B | 0.7% | — |
| 2010 | $0.00 | $231.00M | −$231.00M | 1.11B | 0.7% | — |
| 2009 | $0.00 | $368.50M | −$368.50M | 1.10B | 0.4% | — |
| 2008 | $0.00 | $255.30M | −$255.30M | 1.09B | 0.3% | — |
| 2007 | $0.00 | $0.00 | $0.00 | 1.09B | 0.4% | — |
| 2006 | $122.10M | $0.00 | $122.10M | 1.09B | -0.6% | 0.22% |
| 2005 | $377.90M | $0.00 | $377.90M | 1.09B | 0.3% | 0.61% |
| 2004 | $0.00 | $0.00 | $0.00 | 1.09B | 0.9% | — |
| 2003 | $281.10M | $0.00 | $281.10M | 1.08B | -0.2% | 0.37% |
| 2002 | $385.20M | $0.00 | $385.20M | 1.08B | -0.6% | 0.56% |
| 2001 | $545.70M | $0.00 | $545.70M | 1.09B | -0.5% | 0.65% |
| 2000 | $1.05B | $0.00 | $1.05B | 1.10B | -0.9% | — |
| 1999 | $1.45B | $0.00 | $1.45B | 1.11B | -1.3% | — |
| 1998 | $2.17B | $0.00 | $2.17B | 1.12B | -0.9% | — |
| 1997 | $351.30M | $0.00 | $351.30M | 1.13B | 1.2% | — |
| 1996 | $314.50M | $0.00 | $314.50M | 1.12B | — | — |
| 1995 | $156.00M | $0.00 | $156.00M | — | — | — |
| 1994 | $111.00M | $0.00 | $111.00M | — | — | — |
| 1993 | $25.80M | $0.00 | $25.80M | — | — | — |
| 1992 | $68.50M | $0.00 | $68.50M | — | — | — |
| 1991 | $69.20M | $0.00 | $69.20M | — | — | — |
| 1990 | $1.07B | $0.00 | $1.07B | — | — | — |
| 1989 | $186.90M | $0.00 | $186.90M | — | — | — |
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
TTM buybacks vs headroom (FCF − dividends, TTM)100% of headroom
Headroom $3.59B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Does Eli Lilly buy back its own stock?
- Yes, Eli Lilly (LLY) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
How much does Eli Lilly spend on share buybacks?
- Trailing twelve months (TTM) buyback spend is about $4.11B (sum of the last four quarterly cash-flow periods in our data). Figures are illustrative; verify in filings.
What is Eli Lilly's buyback yield?
- TTM buyback yield is about 0.43% (TTM buyback spend divided by market cap at the latest quarter-end in our data).
What is Eli Lilly's shareholder yield?
- Shareholder yield combines dividend yield and buyback yield. For the latest period we show approximately 0.43% combined (TTM-based where available).
Is Eli Lilly diluting shareholders?
- Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Eli Lilly's share count changed?
- Diluted weighted average shares changed by about -6.1% over roughly five fiscal years (annual income statement data).